Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
10.38
-0.04 (-0.38%)
At close: Jun 27, 2025, 4:00 PM
10.34
-0.04 (-0.39%)
After-hours: Jun 27, 2025, 7:00 PM EDT
Haleon Employees
Haleon had 24,561 employees as of December 31, 2024. The number of employees decreased by 847 or -3.33% compared to the previous year.
Employees
24,561
Change (1Y)
-847
Growth (1Y)
-3.33%
Revenue / Employee
$572,569
Profits / Employee
$73,502
Market Cap
46.55B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24,561 | -847 | -3.33% |
| Dec 31, 2023 | 25,408 | 786 | 3.19% |
| Dec 31, 2022 | 24,622 | 1,822 | 7.99% |
| Dec 31, 2021 | 22,800 | 900 | 4.11% |
| Dec 31, 2020 | 21,900 | 2,900 | 15.26% |
| Dec 31, 2019 | 19,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HLN News
- 4 days ago - HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER - PRNewsWire
- 4 weeks ago - Whitening without the pain: Sensodyne Clinical White gives Canadians a reason to smile - GlobeNewsWire
- 2 months ago - Haleon plc (HLN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Brightseed and Haleon Announce Strategic Collaboration to Harness AI for Small Molecule Discovery and Human Health Innovation - Business Wire
- 2 months ago - Consumer healthcare group Haleon raises medium-term profit forecast - Reuters
- 2 months ago - Haleon reports lower first-quarter revenue hurt by a weaker flu season - Reuters
- 2 months ago - UK's Haleon takes full control of Chinese consumer healthcare venture - Reuters
- 3 months ago - Haleon: A Defensive Play That Makes Sense Amidst The Stock Market Sell-Off - Seeking Alpha